ING Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.12M | Buy |
+8,686
| New | +$2.66M | 0.02% | 365 |
|
|
2026
Q1 | – | Sell |
-14,853
| Closed | -$4.09M | – | 627 |
|
|
2025
Q4 | $4.09M | Sell |
14,853
-17,581
| -54% | -$4.81M | 0.02% | 310 |
|
|
2025
Q3 | $8.51M | Sell |
32,434
-5,557
| -15% | -$1.35M | 0.05% | 211 |
|
|
2025
Q2 | $8.31M | Buy |
37,991
+35,805
| +1,638% | +$7.65M | 0.05% | 187 |
|
|
2025
Q1 | $489K | Sell |
2,186
-2,857
| -57% | -$787K | ﹤0.01% | 442 |
|
|
2024
Q4 | $1.65M | Sell |
5,043
-1,169
| -19% | -$368K | 0.01% | 441 |
|
|
2024
Q3 | $1.86M | Sell |
6,212
-19,390
| -76% | -$5.94M | 0.01% | 428 |
|
|
2024
Q2 | $8.43M | Buy |
+25,602
| New | +$9.05M | 0.05% | 254 |
|
|
2024
Q1 | – | Sell |
-10,129
| Closed | -$3.57M | – | 629 |
|
|
2023
Q4 | $3.57M | Buy |
10,129
+556
| +6% | +$197K | 0.03% | 342 |
|
|
2023
Q3 | $3.59M | Sell |
9,573
-1,033
| -10% | -$399K | 0.03% | 309 |
|
|
2023
Q2 | $4.06M | Buy |
10,606
+9,926
| +1,460% | +$3.55M | 0.03% | 286 |
|
|
2023
Q1 | $236K | Sell |
680
-11,907
| -95% | -$3.48M | ﹤0.01% | 515 |
|
|
2022
Q4 | $2.96M | Buy |
12,587
+981
| +8% | +$232K | 0.03% | 306 |
|
|
2022
Q3 | $2.86M | Sell |
11,606
-2,334
| -17% | -$711K | 0.05% | 235 |
|
|
2022
Q2 | $4.21M | Buy |
13,940
+2,187
| +19% | +$712K | 0.05% | 271 |
|
|
2022
Q1 | $4.83M | Buy |
11,753
+2,084
| +22% | +$816K | 0.05% | 255 |
|
|
2021
Q4 | $4.54M | Buy |
9,669
+3,458
| +56% | +$1.49M | 0.04% | 294 |
|
|
2021
Q3 | $2.64M | Buy |
6,211
+148
| +2% | +$62.4K | 0.03% | 298 |
|
|
2021
Q2 | $2.18M | Buy |
6,063
+5,157
| +569% | +$1.7M | 0.03% | 296 |
|
|
2021
Q1 | $255K | Sell |
906
-3,997
| -82% | -$1.14M | 0.01% | 501 |
|
|
2020
Q4 | $1.39M | Buy |
4,903
+3,269
| +200% | +$917K | 0.03% | 313 |
|
|
2020
Q3 | $449K | Buy |
+1,634
| New | +$432K | 0.02% | 319 |
|
|
2019
Q3 | – | Sell |
-11,264
| Closed | -$1.41M | – | 768 |
|
|
2019
Q2 | $1.41M | Sell |
11,264
-104
| -0.9% | -$12.3K | 0.02% | 322 |
|
|
2019
Q1 | $1.25M | Buy |
11,368
+13
| +0.1% | +$1.35K | 0.03% | 281 |
|
|
2018
Q4 | $1.11M | Buy |
11,355
+113
| +1% | +$12.3K | 0.02% | 314 |
|
|
2018
Q3 | $1.39M | Buy |
+11,242
| New | +$1.26M | 0.02% | 305 |
|
|
2018
Q2 | – | Sell |
-11,254
| Closed | -$994K | – | 861 |
|
|
2018
Q1 | $994K | Buy |
11,254
+8,726
| +345% | +$816K | 0.02% | 329 |
|
|
2017
Q4 | $249K | Buy |
+2,528
| New | +$248K | ﹤0.01% | 685 |
|
|
2017
Q3 | – | Sell |
-8,948
| Closed | -$846K | – | 920 |
|
|
2017
Q2 | $846K | Buy |
+8,948
| New | +$823K | 0.02% | 363 |
|
Other funds holding WST
GIM
ING Group's WST Position: Q2 2026 in Review
ING Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 8,686 shares worth $3.12M. The stake represents 0.02% of the portfolio and ranks #365 among its holdings. This is a return to the name: ING Group previously reported a position in WST as recently as Q4 2025.
ING Group first reported a position in WST in Q2 2017 and has held it in 29 quarters since. The position peaked at $8.51M in Q3 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- ING Group held 8,686 shares of West Pharmaceutical worth $3.12M as of Q2 2026.
- West Pharmaceutical was a new ING Group position in Q2 2026.
- West Pharmaceutical made up 0.02% of ING Group's portfolio in Q2 2026, its #365 holding.
- ING Group first reported a position in West Pharmaceutical in Q2 2017 and has held it in 29 quarters since.
- ING Group's West Pharmaceutical position peaked at $8.51M in Q3 2025.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.